821 results on '"David, Sascha"'
Search Results
202. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland.
203. Angiopoietin-2 levels predict mortality in CKD patients
204. TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease—a prospective follow-up study
205. 18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
206. Effect of Therapeutic Plasma Exchange on Immunoglobulin Deficiency in Early and Severe Septic Shock
207. Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19
208. Modulation of the Permeability-Inducing Factor Angiopoietin-2 Through Bifonazole in Systemic Inflammation
209. Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure
210. Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis
211. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort
212. Author response: Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis
213. Reappearance of effector T cells is associated with recovery from COVID-19
214. Therapeutic plasma exchange in acute on chronic liver failure
215. First do no harm—beware the risk of therapeutic plasma exchange in severe COVID-19
216. Reappearance of Effector T Cells Predicts Successful Recovery from COVID-19
217. Extrakorporale Therapiestrategien in der Sepsis
218. Warum die intensivmedizinische Versorgung in Gefahr ist
219. Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD
220. Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock
221. Non-occlusive mesenteric ischemia (NOMI): evaluation of 2D-perfusion angiography (2D-PA) for early treatment response assessment
222. Corrigendum to: Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic
223. Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD)
224. Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically Ill Patients
225. Covid-19 Immune Signatures Reveal Stable Antiviral T-Cell Function Despite Declining Humoral Responses
226. Circulating angiopoietins in idiopathic pulmonary arterial hypertension
227. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease
228. “Better be awake”—a role for awake extracorporeal membrane oxygenation in acute respiratory distress syndrome due to Pneumocystis pneumonia
229. Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy
230. Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement
231. The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study.
232. Neurological management and work-up of neurotoxicity associated with CAR T cell therapy.
233. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
234. Radio-opaque appearance of lanthanum carbonate in a patient with chronic renal failure
235. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis
236. Circulating soluble urokinase plasminogen receptor is reduced by - and predicts early treatment response to therapeutic plasma exchange in septic shock
237. Everolimus-associated interstitial pneumonitis in a patient with a heart transplant
238. Heavy metal—rely on gut feelings: novel diagnostic approach to test drug compliance in patients with lanthanum intake
239. D-dimer trends in ECMO patients: don't shoot the messenger.
240. Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock.
241. Flow-dependent regulation of endothelial Tie2 by GATA3 in vivo.
242. Additional file 1: of Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers
243. Additional file 1: of Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
244. Additional file 3: of Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers
245. Dual Pharmacological Inhibition of Angiopoietin-2 and VEGF-A in Murine Experimental Sepsis
246. Binding to carboxypeptidase M mediates protective effects of fibrinopeptide Bβ15-42
247. Nonocclusive Mesenteric Ischemia and Interventional Local Vasodilatory Therapy: A Meta-Analysis and Systematic Review of the Literature
248. Dual inhibition of Angiopoietin-2 and VEGF-A with a monoclonal antibody improves pulmonary capillary leakage in murine experimental sepsis
249. Extracorporeal membrane oxygenation as rescue therapy for severe ARDS due to autoimmune diffuse alveolar haemorrhage
250. Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.